Exhibit No.    Description


      99.1     Press release dated December 1, 2004 titled "John Wiley and Sons,
               Inc. Reports First Quarter Results"  (furnished and not filed for
               purposes of Section 18 of the Securities Exchange Act of 1934, as
               amended,  and not deemed  incorporated by reference in any filing
               under the Securities Act of 1934, as amended). ITEM 9: REGULATION
               FD DISCLOSURE The  information in this report is being  furnished
               (i)  pursuant  to  Regulation  FD, and (ii)  pursuant  to item 12
               Results of Operation and Financial  Condition (in accordance with
               SEC interim  guidance  issued March 28, 2003). In accordance with
               General  Instructions B.2 and B.6 of Form 8-K, the information in
               this  report  shall not be deemed to be "filed"  for  purposes of
               Section 18 of the  Securities  Exchange Act of 1934,  as amended,
               nor shall it be deemed  incorporated  by  reference in any filing
               under the Securities  Act of 1934, as amended.  The furnishing of
               the  information set forth in this report is not intended to, and
               does not,  constitute  a  determination  or  admission  as to the
               materiality or completeness of such information.

               On  December  1,  2004,  John  Wiley  &  Sons  Inc.,  a New  York
               corporation  (the "Company"),  issued a press release  announcing
               the Company's  financial results for the second quarter and first
               six  months of fiscal  year  2005.  A copy of the  Company  press
               release is attached hereto as Exhibit 99.1 and incorporated.



Ellis E. Cousens  Executive  VP,  Chief  Financial &  Operations  Officer
John Wiley & Sons, Inc.
(201)748-6534


John Wiley & Sons, Inc. Reports
Revenue and Earnings Growth for its Second Quarter
- --------------------------------------------------

Hoboken,  NJ, December 1, 2004 - John Wiley & Sons, Inc.  (NYSE:JWa)  (NYSE:JWb)
announced today that second quarter revenue of $247.1 million  increased 8% from
$228.9 million in the previous year's second  quarter.  Excluding the effects of
foreign currency gains,  revenue increased 6%. Operating income of $40.1 million
increased 9% from $36.9  million in the same period of the prior year.  Earnings
per  diluted  share  increased  to $0.42 from $0.41 in the prior  year's  second
quarter.

For the first half of fiscal year 2005, Wiley's revenue of $474 million advanced
6%, or 4% excluding the effect of foreign  currency gains.  Operating income for
the six-month period of $70.9 million was up slightly from prior year.  Earnings
per diluted share  declined  slightly from $0.75 to $0.74 mainly due to a higher
effective tax rate.

"Wiley's second quarter  performance was driven primarily by continued  strength
in our global Scientific,  Technical and Medical business. Improved return rates
in Higher Education and  Professional/Trade  in the U.S. also contributed to the
year-on-year  growth,"  said  William  J.  Pesce,  President  & Chief  Executive
Officer.

Mr. Pesce  concluded,  "Based on year-to-date  results,  leading  indicators and
market conditions,  we continue to anticipate revenue and earnings growth in the
mid-to-high single digits in fiscal year 2005."

For the first six months  offiscal  year 2005 the Company has  acquired  959,200
Class A common  shares under an authorized  stock buyback  program at an average
price of $31.96 per share.

Segment Highlights

Professional/Trade (P/T)
- ------------------------
Wiley's U.S. P/T revenue for the second quarter  advanced 3% from the prior year
primarily  due to improved  sales return  experience.  Also  contributing,  were
revenues from  business,  architecture,  professional  culinary,  psychology and
education program titles. Journals and revenue generated through brand licensing
and  website  advertising  also  improved  in the second  quarter.  Year-to-date
revenue was up 1% over the prior year.

Several P/T titles received considerable attention from the media and customers,
including  Tisch/The Power of We: Succeeding Through  Partnerships;  Winget/Shut
Up, Stop Whining and Get a Life;  Obeidi and Pitzer/The  Bomb in My Garden;  and
Wirthlin/The  Greatest  Communicator.  Five Wiley titles were  featured on major



bestseller  lists, The Power of We; Shut Up, Stop Whining,  and Get a Life; Five
Dysfunctions of a Team; Mentored by a Millionaire; and Investing For Dummies.

Second quarter  highlights  also included the  publication of MaGee/Ford  Tough:
Bill Ford and the Battle to Rebuild  America's  Automaker;  Hagstrom/The  Warren
Buffett Way; Taguchi, Chowdhury and Wu/Taguchi's Quality Engineering; Palmer/The
Hidden Wholeness; and The American Medical Association Family Medical Guide. The
second  editions  of  three  bestselling  Windows  XP For  Dummies  titles  were
published  during the  quarter,  tied to  Microsoft's  launch of the  Windows XP
Service Pack 2.

During the quarter, Wiley signed a licensing deal with Acadient for the creation
of a CPA exam review  online course that is expected to go live in January 2005.
The Company also reached an agreement to be Agora  Publishing's  financial  book
publisher. Agora is a premier financial newsletter publisher, whose publications
reach more than one million readers around the world.

Wiley entered into a brand licensing agreement with American Media Inc. (AMI) to
publish For  Dummies-branded  micro magazines that will be sold at cash register
display racks at key mass merchandisers, drug and grocery chain outlets in North
America.  The first four titles of the series,  which were published  during the
quarter,  are  Organizing  For Dummies,  Home  Decorating  For Dummies,  Kitchen
Remodeling For Dummies and Bathroom Remodeling For Dummies.

A redesigned  CliffsNotes.com  launched in August,  forming the cornerstone of a
major brand awareness  initiative and  significantly  increasing  traffic to the
website.  This  colorful,  easy-to-navigate  site offers free online  literature
notes, in-depth product information,  including Quick Reviews,  StudySolvers and
test prep titles,  as well as features  such as "Ask Cliff" and a weekly poll on
timely topics.

Scientific,  Technical,  and Medical  (STM)
- -------------------------------------------
Wiley's  U.S. STM business  continued to exhibit  strength  with revenue up over
prior year by 9% for the quarter and 10% for the six-month period, respectively.
Journal  performance  was  strong,  with new society  publications  contributing
significantly  to the  year-on-year  growth.  STM books also  contributed to the
growth with  year-to-date  revenue for the six-month period up 6% over the prior
year period.

Globally,  STM revenue  increased  approximately  11% for the second quarter and
six-months, reflecting robust journal and book sales.

In addition to healthy renewals,  new Wiley InterScience licenses were signed by
the Chinese  Academy of Sciences,  University of Western  Australia,  Fraunhofer
Gesellschaft,  Saxony Consortium and The Scripps Research  Institute.  Customers
continue to take advantage of Wiley InterScience's wide range of access options,
as  reflected in the  continuing  growth in usage.  Full-text  accesses of Wiley
InterScience journal content was up 25% year-on-year for the six months,  driven
by our ongoing program to enhance the discoverability of our content, including



our participation in CrossRef Search, in collaboration with Google.

During the quarter, STM launched in Wiley InterScience the NeuroScience Backfile
Collection  and  SpecInfo,  a spectral  database  previously  available  only on
CD-ROM.  Several  major  reference  works were also made  available to customers
through Wiley's online service.

Wiley and the Movement  Disorders Society signed a long-term  contract extension
for the publication of its journal, Movement Disorders.  During the quarter, the
Company  also reached an  agreement  with the Society for  Hospital  Medicine to
publish  its  newsletter  as  a  controlled-circulation,   advertising-supported
publication  and to launch its new  flagship  journal,  which is targeted to the
large and growing market of hospital-based medical practitioners.

The global STM book program benefited from a strong frontlist. During the second
quarter,  STM acquired  Ashgate Chemical  References,  a list of 18 chemical and
drug reference titles, from Gower. The list, which includes the long-established
Gardner's  Chemicals  Synonyms and Trade Names,  focuses on the  pharmaceutical,
chemicals and occupational health and safety markets.

Higher Education
- ----------------
Revenue of Wiley's U.S. Higher Education business increased 8% during the second
quarter, bringing year-to-date revenue ahead of prior year. The revenue increase
reflects the combined  effect of improved sales return  experience and growth in
the Social Science and Science programs.

Wiley's innovative online product,  eGrade Plus, was launched  successfully this
summer.  Currently  available with 32 major frontlist  textbooks through several
pricing  options,  eGrade Plus  provides the student with a print and/or  online
textbook,  as well as online  study  guides  and  self-testing  products,  which
provide immediate feedback to help the student succeed in the course. Professors
who adopt  eGrade-Plus  can customize the course  content to fit their  specific
curriculum.

With 50,000 units sold and as many as 15,000 students  accessing  eGrade Plus at
any  given  time,  Wiley has  delivered  uninterrupted  service  this  fall.  In
addition,  more  than  half  of  the  instructors  using  eGrade  Plus  attended
peer-to-peer training sessions led by Wiley's Faculty Resource Network. Students
and faculty have access to Wiley's extensive technical support resources for the
product. Feedback has been positive in the States and abroad.

During the quarter, Higher Education pursued a number of alliances.  The Company
reached an agreement  with  GlobalSpec  to provide its search  functionality  to
engineering  students through eGrade Plus. In addition,  Higher Education worked
with Just Ask! to create  customized  online solution products for 11 of Wiley's
textbooks in various quantitative disciplines.



To offer students more  purchasing  choices,  Higher  Education has been working
with Amazon to help the online  retailer become more effective at selling to the
student market. A market test of Amazon's Search Inside the Book program yielded
positive results.

Europe
- ------
Second  quarter  revenue for Wiley's  European  operations was up 13% over prior
year, or 6% excluding foreign currency effects.  For the first six months of the
year,  Wiley  Europe's  revenue was up 15%,  or 9%  excluding  foreign  currency
effects.

Continuing the positive  trends of the first  quarter,  journal and book revenue
was up. Online sales channels performed  particularly well.  Indigenous products
from both the U.K. and Germany were robust,  as were  imported  U.S. P/T titles.
Sales  of  The  Cochrane  Collection,  which  is  now  available  through  Wiley
InterScience, were strong throughout Europe.

Several  agreements  were created or extended  during the quarter.  The Cochrane
Collaboration  selected  Wiley  as  the  publisher  of  a  series  of  books  in
evidence-based medicine. The Society of Chemical Industry extended its agreement
with Wiley to publish its four primary journals.

Wiley-VCH formed an alliance with the Shanghai Institute of Organic Chemistry, a
part of the Chinese  Academy of  Sciences,  to publish  the  Chinese  Journal of
Chemistry,  the Institute's flagship journal. The journal,  which was founded in
1983,  is  published  in  English  12  times a year and  covers  all  fields  of
chemistry,  including  physical,  organic,  inorganic and analytical,  primarily
through original research papers.

Wiley Europe's general  interest and consumer  publishing  program  continued to
generate   interest,   publicity  and  sales.  Five  months  after  publication,
Barrow/Starting a Business For Dummies,  became the best-selling  small business
title in the U.K. A psychology title,  Iwaniec/Failure  to Thrive, was awarded a
commendation at the British Medical Association book awards.

A noteworthy  development during the quarter was the U.K.  government's response
to the House of Commons Science and Technology Committee inquiry into scientific
publications, dismissing most of the Committee's recommendations and reinforcing
the  views  of  publishers   that  science  is  best  served  by  a  competitive
market-driven approach.

Asia, Australia and Canada
- --------------------------
Wiley's  revenue  in Asia,  Australia  and  Canada  was up 7% during  the second
quarter,  or 3% excluding  foreign currency  effects.  For the six-month period,
revenue increased 4%, but was flat excluding foreign exchange effects.

In Asia, all Wiley's businesses  contributed to the growth,  with strong results
in India, the Philippines, Thailand, Indonesia and Japan. Second quarter results
were slightly  lower than expected in  Australia,  primarily  because of delayed
ordering for the school market.



Wiley  Canada's  performance  during the second  quarter  was mixed with  Higher
Education falling short of prior year, while P/T delivered solid results.

eGrade  Plus was rolled out  internationally,  driving  sales in  Australia  and
Canada  by  helping  to win  new  adoptions,  as well  as  maintaining  existing
business. eGrade Plus is now being used at Tongji University in China.

The Australian  Campus  Booksellers  Association  and the Australian  Publishers
Association  have named Wiley Australia as "Tertiary  Publisher of the Year" and
"Secondary  Publisher  of the Year,"  respectively.  Wiley has won these  awards
consistently over the last five years.


Conference Call
Wiley will hold a conference call today,  Wednesday,  December 1, 2004, at 10:30
a.m.  (EST) to discuss its  financial  results for the second  quarter of fiscal
year 2005. The call will include a brief management  presentation  followed by a
question and answer session.

To  participate  in the  conference  call,  please  dial  the  following  number
approximately ten minutes prior to the scheduled starting time: (800) 474-8920

International callers may participate by dialing: (719) 457-2727

A  replay  of  the  call   will  be   available   from   1:30   p.m.   (EST)  on
Wednesday,December  1  through  midnight  (EST)  on  Tuesday,   December  7,  by
dialing:(719)457-0820 or (888) 203-1112 and entering Passcode 988587.

A      live      audio       Webcast      will      be       accessible       at
http://www.wiley.com/go/communications.   A  replay  of  the  Webcast   will  be
accessible for 14 days afterwards.


"Safe Harbor"  Statement under the Private  Securities  Litigation Reform Act of
1995
This report contains certain forward-looking statements concerning the Company's
operations,  performance, and financial condition. Reliance should not be placed
on  forward-looking  statements,  as actual results may differ  materially  from
those in any forward-looking statements. Any such forward-looking statements are
based upon a number of assumptions and estimates that are inherently  subject to
uncertainties  and  contingencies,  many of which are beyond the  control of the
Company, and are subject to change based on many important factors. Such factors
include,  but are not limited to (i) the level of investment in new technologies
and products;  (ii)subscriber renewal rates for the Company's journals; (iii)the
financial  stability  and  liquidity  of journal  subscription  agents;  (iv)the
consolidation of book  wholesalers and retail  accounts;  (v)the market position
and financial stability of key online retailers;  (vi)the seasonal nature of the
Company's  educational  business  and  the  impact  of  the  used  book  market;
(vii)worldwide economic and political conditions; (viii)the Company's ability to
protect its copyrights and other  intellectual  property worldwide and (ix)other
factors detailed from time to time in the Company's  filings with the Securities
and Exchange Commission.



The   Company   undertakes   no   obligation   to  update  or  revise  any  such
forward-looking statements to reflect subsequent events or circumstances.

Founded  in 1807,  John  Wiley & Sons,  Inc.,  provides  must-have  content  and
services  to  customers  worldwide.  Its  core  businesses  include  scientific,
technical, and medical journals,  encyclopedias,  books, and online products and
services;  professional  and  consumer  books  and  subscription  services;  and
educational  materials  for  undergraduate  and  graduate  students and lifelong
learners.  Wiley has  publishing,  marketing,  and  distribution  centers in the
United States, Canada, Europe, Asia, and Australia. The Company is listed on the
New York Stock Exchange under the symbols JWa and JWb. Wiley's Internet site can
be accessed at http://www.wiley.com.







                            JOHN WILEY & SONS, INC.
                             SUMMARY OF OPERATIONS
                  FOR THE SECOND QUARTER AND SIX MONTHS ENDED
                           OCTOBER 31, 2004 AND 2003
                    (in thousands, except per share amounts)


                                                         Second Quarter Ended                        Six Months Ended
                                                              October 31,                               October 31,
                                                 ---------------------------------------      -----------------------------------
                                                      2004         2003        % Change           2004        2003       % Change
                                                 -----------    ---------     ----------      ----------    ---------    --------
                                                                                                           
Revenue                                          $   247,050     228,880          8%            473,989      448,540          6%

Costs and Expenses
     Cost of Sales                                    85,247      78,182          9%            160,476      150,291          7%
     Operating and Administrative Expenses           119,168     111,296          7%            237,602      223,339          6%
     Amortization of Intangibles                       2,511       2,535         -1%              5,010        4,865          3%
                                                 -----------    ---------                     ----------    ---------
     Total Costs and Expenses                        206,926     192,013          8%            403,088      378,495          6%
                                                 -----------    ---------                     ----------    ---------

Operating Income                                      40,124      36,867          9%             70,901       70,045          1%
     Operating Margin                                  16.2%       16.1%                          15.0%        15.6%

Interest Expense and Other, Net                        1,560         612                          2,747        1,872
                                                 -----------    ---------                     ----------    ---------

Income Before Taxes                                   38,564      36,255          6%             68,154       68,173          0%

Provision for Income Taxes                            12,105      10,607                         21,811       20,725
                                                 -----------    ---------                     ----------    ---------

Net Income                                       $    26,459      25,648          3%             46,343       47,448         -2%
                                                 ===========    =========                     ==========    =========

Income Per Share
     Diluted                                     $      0.42        0.41          4%               0.74         0.75         -2%
     Basic                                       $      0.43        0.41                           0.76         0.77


Average Shares
     Diluted                                          62,548      63,176                         62,731       63,091
     Basic                                            61,054      61,891                         61,240       61,788








                            JOHN WILEY & SONS, INC.
                                SEGMENT RESULTS
                  FOR THE SECOND QUARTER AND SIX MONTHS ENDED
                           OCTOBER 31, 2004 AND 2003
                    (in thousands, except per share amounts)


                                                  Second Quarter Ended                    Six Months Ended
                                                      October 31,                             October 31,
                                         ---------------------------------------  -------------------------------------
                                            2004          2003         % Change     2004          2003        % Change
                                         ----------     --------       ---------  ---------     --------      ---------
                                                                                                 
Revenue
- ----------------------------------------
US Segment
     Professional/Trade                 $    89,089       86,531           3%       164,997      162,675           1%
     Scientific, Technical and Medical       46,696       42,694           9%        92,902       84,401          10%
     Higher Education                        40,675       37,674           8%        86,150       85,442           1%
                                         -----------    ---------                  ---------    ---------
Total US                                    176,460      166,899           6%       344,049      332,518           3%
European Segment                             67,725       60,018          13%       127,248      110,601          15%
Asia, Australia & Canada Segment             26,932       25,077           7%        50,398       48,473           4%
Intersegment Sales Eliminations             (24,067)     (23,114)          4%       (47,706)     (43,052)         11%
                                         -----------    ---------                  ---------    ---------
Total Revenue                           $   247,050      228,880           8%       473,989      448,540           6%
                                         ===========    =========                  =========    =========

Direct Contribution to Profit
- ----------------------------------------
US Segment
     Professional/Trade                 $    26,155       25,382           3%        41,706       43,570          -4%
     Scientific, Technical and Medical       21,397       20,503           4%        43,666       41,219           6%
     Higher Education                        12,392        9,935          25%        28,443       28,619          -1%
                                         -----------    ---------                  ---------    ---------
Total US                                     59,944       55,820           7%       113,815      113,408           0%
European Segment                             21,814       19,230          13%        40,508       34,652          17%
Asia, Australia & Canada Segment              5,813        5,480           6%         9,004        9,623          -6%
                                         -----------    ---------                  ---------    ---------
Total Direct Contribution to Profit          87,571       80,530           9%       163,327      157,683           4%

Shared Services and Administrative Costs
- ----------------------------------------
     Distribution                           (12,019)     (11,591)          4%       (23,758)     (22,852)          4%
     Information Technology & Development   (12,963)     (12,428)          4%       (25,232)     (24,229)          4%
     Finance                                 (7,901)      (7,189)         10%       (15,240)     (14,240)          7%
     Other Administration                   (14,564)     (12,455)         17%       (28,196)     (26,317)          7%
                                         -----------    ---------                  ---------    ---------
Total Shared Services and Admin. Costs      (47,447)     (43,663)          9%       (92,426)     (87,638)          5%

Operating Income                        $    40,124       36,867                     70,901       70,045
                                         ===========    =========                  =========    =========








                            JOHN WILEY & SONS, INC.
                   CONDENSED STATEMENTS OF FINANCIAL POSITION
                                 (in thousands)
                                                                                        October 31,
                                                                                --------------------------      April 30,
                                                                                    2004          2003            2004
                                                                                ----------     ---------       ---------
                                                                                                          
Current Assets
       Cash & cash equivalents                                           $         18,359        10,756          82,027
       Accounts receivable                                                        142,066       147,124         127,224
       Inventories                                                                 77,672        84,049          83,789
       Deferred income tax benefit                                                 18,041        27,482          18,113
       Other current assets                                                        11,638         9,047          12,853
                                                                                ----------     ---------     -----------
       Total Current Assets                                                       267,776       278,458         324,006
Product Development Assets                                                         59,231        61,353          60,755
Property and Equipment                                                            114,758       116,815         117,305
Intangible Assets                                                                 280,736       279,697         276,440
Goodwill                                                                          195,354       194,114         194,893
Deferred income tax benefit                                                        17,503        28,046          18,976
Other Assets                                                                       21,917        22,310          22,207
                                                                                ----------     ---------     -----------
       Total Assets                                                               957,275       980,793       1,014,582
                                                                                ==========     =========     ============
Current Liabilities
       Notes payable & current portion of long-term debt                              -          60,000             -
       Accounts and royalties payable                                              71,056        91,080          68,338
       Deferred subscription revenues                                              50,103        42,665         127,224
       Accrued income taxes                                                        30,352        28,962          19,338
       Deferred income taxes                                                        5,784           -             5,721
       Other accrued liabilities                                                   69,342        61,114          85,744
                                                                                ----------     ---------     ------------
       Total Current Liabilities                                                  226,637       283,821         306,365
Long-Term Debt                                                                    200,000       200,000         200,000
Accrued Pension Liability                                                          52,171        56,378          48,505
Other Long-Term Liabilities                                                        31,250        28,997          31,757
Deferred Income Taxes                                                              12,543        12,185          12,891
Shareholders' Equity                                                              434,674       399,412         415,064
                                                                                ----------     ---------     ------------
       Total Liabilities & Shareholders' Equity                            $      957,275       980,793       1,014,582
                                                                                ==========     =========     ============





                       CONDENSED STATEMENTS OF CASH FLOWS

                                                                                   Six Months Ended
                                                                                      October 31,
                                                                              ---------------------------
                                                                                 2004             2003
                                                                              ----------       ----------
                                                                                             
Operating Activities
       Net income                                                      $        46,343           47,448
       Amortization of intangibles                                               5,010            4,865
       Amortization of composition costs                                        16,569           15,254
       Depreciation of property and equipment                                   15,123           13,720
       Other non-cash items                                                     28,850           25,030
       Change in deferred subscription revenue                                 (77,965)         (77,444)
       Net change in operating assets and liabilities                          (14,151)         (29,404)
                                                                              ----------       ----------
       Cash Provided by (Used for) Operating Activities                         19,779             (531)

Investing Activities
       Additions to product development assets                                 (28,255)         (26,305)
       Additions to property and equipment                                     (10,984)         (13,140)
       Acquisition of publishing assets, net of cash acquired                   (7,662)          (1,904)
                                                                              ----------       ----------
       Cash Used for Investing Activities                                      (46,901)         (41,349)

Financing Activities
       Borrowings of short-term debt                                                 -           60,000
       Repayment of long-term debt                                                   -          (35,000)
       Purchase of treasury shares                                             (30,657)          (2,486)
       Cash dividends                                                           (9,103)          (8,079)
       Proceeds from exercise of stock options                                   2,853            3,287
                                                                              ----------       ---------
       Cash (Used for) Provided by Financing Activities                        (36,907)          17,722

Effects of Exchange Rate Changes on Cash                                           361            1,673
                                                                              ----------       ----------

Decrease in Cash and Cash Equivalents for Period                       $       (63,668)         (22,485)
                                                                              ==========       ==========